PrescriptSure, Inc. — SEC Form D Filing

PrescriptSure, Inc. filed an SEC Form D on September 22, 2026, reporting $250K raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
September 22, 2026
Amount reported
$250K
Round stage
Pre-Seed
Industry
Healthcare Technology
Website
https://prescriptsure.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Outpatient practices face significant inefficiencies and staff workload due to rejected prescriptions, coverage surprises, and prior authorization issues, leading to delays in patient care and numerous pharmacy callbacks.

Solution

PrescriptSure provides a tool that allows healthcare teams to verify prescription coverage, check prior authorization requirements, and identify covered alternatives before sending prescriptions, thereby avoiding pharmacy callbacks and staff follow-up.

Why now

Healthcare systems and outpatient practices are under increasing pressure to improve efficiency and reduce administrative burden, making solutions that streamline prescription workflows highly valuable.

Verdict

This cleared because investors saw a high-frequency, painful administrative problem with a direct software solution, not because it promised a revolutionary shift in healthcare. They were implicitly betting on capturing a segment of the existing healthcare IT budget by selling a workflow optimization tool that offered immediate, measurable efficiency gains to clinic administrators. The upside was limited by the relatively small addressable market for a point solution and the potential for larger EHR vendors or existing infrastructure players to integrate similar functionalities, making it a feature rather than a standalone platform.

Source: SEC EDGAR Form D filing